Jenburkt Pharmaceuticals Ltd manufactures and markets branded Pharmaceuticals and health care productsBusiness Overview: JPL manufactures and markets pharmaceutical formulations in India and internationally across 13 countries. It promotes 85 brands across 1 Lac+ doctors regularly. Company has 1,000+ stockists and its reach extends to 4 Lac+ pharmacies across the globe....
The company's shareholders at the 41st Annual General Meeting have approved the re-appointment of Shri Dilip H. Bhuta as Whole Time Director and CFO for a period of five years, effective from April 1, 2027, to March 31, 2032. His remuneration has also been approved for three years starting April...
Submission of consolidated Voting Results and Scrutinizer''s Report on all the Resolutions as set out in the Notice Convening the 41st AGM of the Company held on 04th September, 2026.
The company has announced the proceedings of its 41st Annual General Meeting. This pivotal corporate event serves as a crucial platform for shareholders to actively engage in the company's governance and strategic oversight. Such meetings are fundamental for reviewing operational performance, understanding financial standing, and participating in key decisions. They...
Summary of the proceedings of the 41st Annual General Meeting of the Company held on Friday, 04th September, 2026.
Jenburkt Pharmaceuticals has elevated Shri. Prem Ashish Bhuta from Management Associate to Associate Vice President (AVP) – Strategic Initiatives, a key Senior Management position. The Board approved this internal promotion following a proposal from the Nomination and Remuneration Committee. Shri. Bhuta, who is related to the Promoter and Chairman &...
